Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2021-10-25 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
关于召开2021年第五次临时股东大会的通知
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed notice about convening the 2021 fifth extraordinary general meeting (临时股东大会) of the company, including information on meeting date, voting methods (onsite and online), agenda items, registration procedures, and attachments such as proxy forms and voting instructions. It does not contain financial statements, audit results, or earnings data. It is not a report itself but a formal announcement and notice to shareholders about the meeting and voting process. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting arrangements rather than solicitation materials or proxy statements, the best fit is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4863 characters, which is consistent with a detailed meeting notice rather than a full report or transcript.
2021-10-25 Chinese
北京德恒（厦门）律师事务所关于大博医疗科技股份有限公司2021年限制性股票激励计划回购注销部分限制性股票的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's 2021 restricted stock incentive plan and the repurchase and cancellation of some restricted shares. It discusses legal compliance, approvals by the board, supervisory board, and shareholders, and details about the repurchase price, quantity, and procedures. It is not a financial report, earnings release, or regulatory filing per se, but a legal opinion related to a specific corporate action (stock incentive plan and repurchase). This type of document is best classified as a Regulatory Filing (RNS) because it is a legal opinion letter and does not fit into other specific categories such as Capital/Financing Update or Director's Dealing. The document length is 6815 characters, which is substantial but it is not a report or announcement of a report publication. Therefore, the best fit is Regulatory Filings (RNS).
2021-10-25 Chinese
2021年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '大博医疗科技股份有限公司 2021 年半年度财务报告' which translates to 'Dabo Medical Technology Co., Ltd. 2021 Semi-Annual Financial Report'. It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2021. The report explicitly states it is a half-year (semi-annual) financial report and includes comprehensive financial data and analysis for that period. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-25 Chinese
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 95% confidence The document is an independent opinion statement from the independent directors of the company regarding the use and storage of raised funds for the half-year period of 2021, as well as related party fund occupation and external guarantees. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules. The content is a specialized audit or compliance opinion on specific financial matters rather than a full financial report or earnings release. The document length is short (761 characters) and it contains detailed independent opinions on financial compliance matters, which aligns with an Audit Report / Information filing rather than a full Annual Report or Interim Report. Therefore, the document is best classified as an Audit Report / Information (AR). H1 2021
2021-08-25 Chinese
半年报监事会决议公告
Report Publication Announcement Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Dabao Medical Technology Co., Ltd. regarding the approval of the 2021 semi-annual report and a special report on the use of raised funds. It states that the full semi-annual report is available on the Shenzhen Stock Exchange designated information disclosure website and that the summary was published in newspapers. The document itself does not contain the full semi-annual report or detailed financial data but rather announces the approval and availability of these reports. The document length is short (1021 characters), and it serves as an announcement rather than the report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2021-08-25 Chinese
半年报董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a board meeting resolution announcement from 大博医疗科技股份有限公司 dated August 26, 2021. It reports the approval of the 2021 semi-annual report and a special report on the use of raised funds. The document states that the full semi-annual report and related materials are available on external websites and newspapers, indicating this document itself is not the full report but an announcement of the board's approval and the availability of the report elsewhere. The document length is short (825 characters), consistent with an announcement rather than a full report. Therefore, this fits the category of a Regulatory Filing (RNS) as it is a formal announcement of board resolutions and report approvals without containing the full financial data or detailed report content itself.
2021-08-25 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.